» Articles » PMID: 39263295

Changes in Short-chain Fatty Acids Affect Brain Development in Mice with Early Life Antibiotic-induced Dysbacteriosis

Overview
Journal Transl Pediatr
Specialty Pediatrics
Date 2024 Sep 12
PMID 39263295
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Early enteral nutrition and the gut microbiota profoundly influence neonatal brain development, with short-chain fatty acids (SCFAs) from the microbiota playing a pivotal role. Understanding the relationship between dysbiosis, SCFAs, and brain development is crucial. In this study, we investigated the impact of antibiotics on the concentration of SCFAs in neonatal feces. Additionally, we developed a model of gut dysbiosis in neonatal mice to examine the potential relationship between this imbalance, SCFAs production, and brain function development.

Methods: We measured the SCFAs content in the feces of two groups of neonates, categorized based on whether antibiotics were used, and conducted the Neonatal Behavioral Neurological Assessment (NBNA) test on all neonates. Then we evaluated fecal SCFAs levels in neonates and neonatal mice post-antibiotic treatment using liquid chromatography-mass spectrometry (LC-MS) analysis. Morris water maze (MWM) tests assessed behavioral performance, and western blot analysis examined brain tissue-related proteins-neuron-specific enolase (NSE), ionized calcium binding adaptor molecule-1 (IBA1), and myelin basic proteins (MBP).

Results: The use of antibiotics did not affect the NBNA scores of the two groups of neonates, but it did reduce the SCFAs content in their feces. Antibiotic administration induced gut dysbiosis in mice, resulting in decreased IBA1 and MBP expression. Interventions to restore gut microbiota ameliorated these effects. Mice with dysbiosis displayed cognitive deficits in the MWM test. SCFAs levels decreased during dysbiosis, and increased upon microbiota recovery.

Conclusions: Neonatal dysbiosis affects the microbiota-gut-brain axis, impairing cognitive function and nervous system development. Reduced SCFAs may contribute significantly to these alterations.

References
1.
Lier J, Winter K, Bleher J, Grammig J, Mueller W, Streit W . Loss of IBA1-Expression in brains from individuals with obesity and hepatic dysfunction. Brain Res. 2019; 1710:220-229. DOI: 10.1016/j.brainres.2019.01.006. View

2.
Xiong Y, Miyamoto N, Shibata K, Valasek M, Motoike T, Kedzierski R . Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc Natl Acad Sci U S A. 2004; 101(4):1045-50. PMC: 327148. DOI: 10.1073/pnas.2637002100. View

3.
Bourassa M, Alim I, Bultman S, Ratan R . Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health?. Neurosci Lett. 2016; 625:56-63. PMC: 4903954. DOI: 10.1016/j.neulet.2016.02.009. View

4.
Forbes J, Van Domselaar G, Bernstein C . Microbiome Survey of the Inflamed and Noninflamed Gut at Different Compartments Within the Gastrointestinal Tract of Inflammatory Bowel Disease Patients. Inflamm Bowel Dis. 2016; 22(4):817-25. DOI: 10.1097/MIB.0000000000000684. View

5.
Ohsawa K, Imai Y, Sasaki Y, Kohsaka S . Microglia/macrophage-specific protein Iba1 binds to fimbrin and enhances its actin-bundling activity. J Neurochem. 2004; 88(4):844-56. DOI: 10.1046/j.1471-4159.2003.02213.x. View